Macralytics CMS

    • Home
    • MIPS Measures

Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)

Written by

in

←RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer Who Receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy
Percentage of Patients who Died from Cancer Admitted to Hospice for Less than 3 Days (lower score – better)→

More posts

  • Quality Payment Program (QPP): Complete Guide

    June 12, 2026

Macralytics CMS

  • Blog
  • About
  • FAQs
  • Authors
  • Events
  • Shop
  • Patterns
  • Themes

Twenty Twenty-Five

Designed with WordPress